BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28969940)

  • 1. Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
    Cabral MS; Santos TPS; Santos PL; Schinoni MI; Oliveira IS; Pereira AB; Atta AM; Sousa-Atta MLB
    Cytokine; 2018 Feb; 102():200-205. PubMed ID: 28969940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
    Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
    Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.
    Meng P; Zhao S; Niu X; Fu N; Su S; Wang R; Zhang Y; Qiao L; Nan Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
    Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
    Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.
    Hao C; Zhou Y; He Y; Fan C; Sun L; Wei X; Wang L; Peng M; Wang P; Lian J; Jia Z
    Immunology; 2014 Dec; 143(4):531-8. PubMed ID: 24903732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy.
    Fathy A; Ahmed AS; Metwally L; Hassan A
    Med Princ Pract; 2011; 20(4):345-9. PubMed ID: 21576995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the cellular immune response in HIV/HCV patients with hemophilia during peginterferon/ribavirin therapy in southern China.
    Yingying L; Jiangrong W; Jing L
    Diagn Microbiol Infect Dis; 2014 Jan; 78(1):45-8. PubMed ID: 24183601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 and IL-17 as Predictors of Hepatic Inflammation in Patients with Chronic Hepatitis C Virus Infection and Treated With Direct Antiviral Therapy.
    Abou El-Khier NT; Elhammady D; Arafa MM; Shahin D; Eladl E; Abousamra NK; Sharaf-Eldeen O; Shaker G; Esmael ME
    Egypt J Immunol; 2018 Jun; 25(2):61-74. PubMed ID: 30600949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C.
    Lechmann M; Woitas RP; Langhans B; Kaiser R; Ihlenfeldt HG; Jung G; Sauerbruch T; Spengler U
    J Hepatol; 1999 Dec; 31(6):971-8. PubMed ID: 10604568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment.
    Silva JPCG; Jesus LS; Isabel Schinoni M; Oliveira IS; Atta MLBS; Atta AM
    Int Immunopharmacol; 2021 Apr; 93():107405. PubMed ID: 33529909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells.
    Schlaak JF; Pitz T; Löhr HF; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1998 Oct; 56(2):112-7. PubMed ID: 9746065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha-ribavirin treatment.
    Pham TN; Lin DM; Mulrooney-Cousins PM; Churchill ND; Kowala-Piaskowska A; Mozer-Lisewska I; Machaj A; Pazgan-Simon M; Zalewska M; Simon K; King D; Reddy SB; Michalak TI
    J Med Virol; 2013 Mar; 85(3):441-8. PubMed ID: 23280583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.
    Graham CS; Wells A; Liu T; Sherman KE; Peters M; Chung RT; Bhan AK; Andersen J; Koziel MJ;
    AIDS; 2006 Feb; 20(3):345-51. PubMed ID: 16439867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript analysis of P2X receptors in PBMCs of chronic HCV patients: an insight into antiviral treatment response and HCV-induced pathogenesis.
    Ashraf W; Manzoor S; Ashraf J; Ahmed QL; Khalid M; Tariq M; Imran M; Aziz H
    Viral Immunol; 2013 Oct; 26(5):343-50. PubMed ID: 24116708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
    Legrand E; Neau D; Galperine T; Trimoulet P; Moreau JF; Pitard V; Lacut JY; Ragnaud JM; Dupon M; Le Bail B; Bernard N; Schvoerer E; Houghton M; Fleury H; Lafon ME
    J Infect Dis; 2002 Aug; 186(3):302-11. PubMed ID: 12134226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C.
    Amador-Cañizares Y; Alvarez-Lajonchere L; Guerra I; Rodríguez-Alonso I; Martínez-Donato G; Triana J; González-Horta EE; Pérez A; Dueñas-Carrera S
    World J Gastroenterol; 2008 Nov; 14(44):6844-52. PubMed ID: 19058312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.